Lipid lowering therapy in elderly patients with stable angina

We evaluate the brachiocephalic trunk arteries remodeling in 197 patients with stable angina Canadian class I and II treated with lipid lowering therapy within 1 year. In patients of group 1 treated with high dose of rosuvastatin (20 mg daily) and group 2 treated with atorvastatin 40 mg daily with dose escalation and possible addition of ezetimibe 10 mg daily to achieve the target level of LDL or ≥ 50% of its initial level decreasing we observed regression of atherosclerosis in brachiocephalic trunk arteries. In patients of group 3 who received moderate dose of simvastatin (40 mg daily) we revealed stabilization of atherosclerosis in brachiocephalic trunk arteries.